Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025)

Evolus (EOLS) reported Asset Writedowns and Impairment of $2.2 million for Q3 2025, up 148.59% on a YoY basis from $889000.0 in Q3 2024, and up 214.37% quarter-over-quarter from $703000.0 in Q2 2025.

Evolus (EOLS) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends

Evolus has reported Asset Writedowns and Impairment for 7 years, with the latest figure at $2.2 million in Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment rose 148.59% year-over-year to $2.2 million; the trailing twelve-month figure through Sep 2025 stood at $4.8 million (up 172.44% YoY), and the FY2024 full-year result was $2.4 million, up 70.07% from the prior year.
  • Asset Writedowns and Impairment for Q3 2025 stood at $2.2 million, up from $703000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $2.2 million in Q3 2025, with the low at -$297000.0 in Q2 2021.
  • Historically, Asset Writedowns and Impairment has averaged $528421.1 across 5 years, with a median of $465000.0 in 2022.
  • Annual changes were most pronounced in 2021 — Asset Writedowns and Impairment slumped 76.6% — and 2024, when it soared 818.6%.
  • Evolus' Asset Writedowns and Impairment stood at $88000.0 in 2021, then jumped by 167.05% to $235000.0 in 2022, then tumbled by 63.4% to $86000.0 in 2023, then soared by 818.6% to $790000.0 in 2024, then surged by 179.75% to $2.2 million in 2025.
  • The last three Asset Writedowns and Impairment figures came in at $2.2 million (Q3 2025), $703000.0 (Q2 2025), and $1.1 million (Q1 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn
10 Evolus 437.40 Mn 387.61 Mn 48.90 Mn

Historic Data

Download Data
DateValue
Sep 30, 2025 2.21 Mn
Sep 30, 2025 2.21 Mn
Jun 30, 2025 703,000.00
Jun 30, 2025 703,000.00
Mar 31, 2025 1.05 Mn
Mar 31, 2025 1.05 Mn
Dec 31, 2024 790,000.00
Dec 31, 2024 790,000.00
Sep 30, 2024 889,000.00
Sep 30, 2024 889,000.00
Jun 30, 2024 582,000.00
Jun 30, 2024 582,000.00
Mar 31, 2024 188,000.00
Mar 31, 2024 188,000.00
Dec 31, 2023 86,000.00
Dec 31, 2023 86,000.00
Sep 30, 2023 1.01 Mn
Sep 30, 2023 1.01 Mn
Jun 30, 2023 69,000.00
Jun 30, 2023 69,000.00